- Report
- December 2024
- 110 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 350 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- April 2025
- 179 Pages
Global
From €4362EUR$4,995USD£3,790GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2025
- 389 Pages
Global
From €3665EUR$4,197USD£3,184GBP
- Report
- April 2025
- 138 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- March 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- March 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 190 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 199 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 370 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 170 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 275 Pages
Global
From €5109EUR$5,850USD£4,438GBP

Autologous cell therapy is a type of regenerative medicine that uses a patient's own cells to treat a variety of diseases and conditions. It is a form of personalized medicine that is based on the patient's own genetic makeup. Autologous cell therapy is used to treat a variety of conditions, including cancer, autoimmune diseases, and degenerative diseases. Genomics plays an important role in autologous cell therapy, as it allows for the identification of the patient's own cells and the selection of the most appropriate cells for the therapy. Genomics also helps to identify the best treatment strategy for the patient, as well as to monitor the progress of the therapy.
Some companies in the autologous cell therapy market include Celgene, Novartis, and Kite Pharma. Show Less Read more